Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antiinfectious prophylaxis in asplenia].

S W Eber1, B H Belohradsky, M Weiss

  • 1Abt. Immunol./Hämotol./Onkol., Univ.-Kinderklinik Zürich, Zurich, Switzerland. stefan.eber@kispi.unizh.ch

Klinische Padiatrie
|September 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A human immunodeficiency syndrome caused by mutations in CARMIL2.

Nature communications·2017
Same author

Inflammatory pseudotumor (IPT)-surgical cure of an inflammatory syndrome.

European journal of pediatrics·2016
Same author

Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.

Allergy·2014
Same author

X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.

Clinical immunology (Orlando, Fla.)·2013
Same author

The German national registry for primary immunodeficiencies (PID).

Clinical and experimental immunology·2013
Same author

Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy.

Clinical and experimental immunology·2012
Same journal

Guidance for the Diagnosis and Treatment of Rare Embryonal and Sarcomatous Brain Tumors-a Report from the Central Nervous System-International Registry for Rare Embryonal and Sarcomatous Tumors German Society of Pediatric Oncology and Hematology Study Group.

Klinische Padiatrie·2026
Same journal

Klinische Padiatrie·2026
Same journal

Association of Fat-free Mass Index and Body Mass Index on Pulmonary Function Tests in Children with Rheumatological Disease-associated Interstitial Lung Disease.

Klinische Padiatrie·2026
Same journal

Synchronous Differentiated Thyroid Carcinoma and Nonthyroid Malignancies in Pediatric Patients: A Registry-based Case Series.

Klinische Padiatrie·2026
Same journal

Intrauterine Ulceration of the Lower Limbs: A Not-so-rare Complication Following Vesicoamniotic Shunting with Somatex.

Klinische Padiatrie·2026
Same journal

Letter to the Editor Regarding the Article "Near-Fatal Asthma Due to Severe Airway Mucus Plugging in a 12-Year-Old Boy".

Klinische Padiatrie·2026
See all related articles

Children without a spleen face a high risk of severe infections, primarily from Streptococcus pneumoniae. Vaccinations and antibiotic prophylaxis are crucial, and splenectomy indications in children should be carefully considered.

Area of Science:

  • Pediatric Medicine
  • Immunology
  • Hematology

Background:

  • Asplenia in children can be congenital or acquired, with hereditary spherocytosis being a common reason for splenectomy.
  • Patients without a spleen have a significantly increased risk of severe postsplenectomy infections, particularly those caused by Streptococcus pneumoniae.

Purpose of the Study:

  • To outline the risks associated with childhood asplenia and emphasize preventive strategies.
  • To discuss current recommendations for vaccinations and antibiotic prophylaxis in asplenic children.
  • To re-evaluate the indications for splenectomy in pediatric hematologic conditions.

Main Methods:

  • Review of existing literature on childhood asplenia, postsplenectomy infections, and management strategies.
  • Analysis of vaccination protocols and antibiotic prophylaxis guidelines.

Related Experiment Videos

  • Discussion of the evolving landscape of pneumococcal resistance and its impact on treatment.

    • Main Results:

    • Asplenic children require vaccinations against pneumococci, Haemophilus influenzae, and meningococci.
    • Continuous antibiotic prophylaxis for at least three years post-splenectomy is recommended, with lifelong intervention for unclear infections.
    • Penicillin resistance in pneumococci may limit future prophylaxis options, necessitating restricted splenectomy indications.

    Conclusions:

    • Splenectomy in childhood should be reserved for hematologic diseases with moderate to severe symptoms.
    • Preserving splenic remnants after trauma is advisable.
    • Further research is needed on the efficacy of partial splenectomy in managing hemolysis and preventing infections.